Drug Trial Radar · NCT07223138
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
1,560
Planned (sponsor's estimate)
Start
Nov 13, 2025
Primary completion
Feb 4, 2028
Study completion Feb 4, 2028
Sponsor
- Lead sponsor
- MoonLake Immunotherapeutics AGIndustry
- Sponsor type
- Industry
- First posted
- Oct 31, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to demonstrate the long-term safety, tolerability and clinical efficacy of sonelokimab in the treatment of patients with psoriatic arthritis who completed a parental study (M1095-PSA-301 or M1095-PSA-302)
Conditions
- Arthritis, Psoriatic
Interventions
SonelokimabDrug
Open-label
Primary outcomes
What the sponsor says the trial is designed to measure.
- Long-term safety and tolerability of sonelokimab:Time frame: 52 weeks
- Long-term safety and tolerability of sonelokimab:Time frame: 52 weeks
- Long-term safety and tolerability of sonelokimab:Time frame: 52 weeks
- Long-term safety and tolerability of sonelokimab:Time frame: 52 weeks
- Long-term safety and tolerability of sonelokimab:Time frame: 52 weeks
- Long-term safety and tolerability of sonelokimab:Time frame: 52 weeks
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Clinical Site
Avondale, Arizona
Clinical Site
Mesa, Arizona
Clinical Site
Phoenix, Arizona
Clinical Site
Scottsdale, Arizona
Clinical Site
Tucson, Arizona
Clinical Site
Jonesboro, Arkansas
Clinical Site
Upland, California
Clinical Site
Avon Park, Florida
Clinical Site
Clearwater, Florida
Clinical Site
Tampa, Florida
Clinical Site
Baltimore, Maryland
Clinical Site
Charlotte, North Carolina
Clinical Site
Leland, North Carolina
Clinical Site
Middleburg Heights, Ohio
Clinical Site
Duncansville, Pennsylvania
Clinical Site
Memphis, Tennessee
Clinical Site
Baytown, Texas
Clinical Site
Lubbock, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.